Technical Analysis for GERN - Geron Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | -1.44% | |
| Outside Day | Range Expansion | -1.44% | |
| NR7 | Range Contraction | -3.72% | |
| Narrow Range Bar | Range Contraction | -3.72% | |
| Crossed Above 20 DMA | Bullish | -3.72% | |
| 180 Bullish Setup | Bullish Swing Setup | -3.72% | |
| Gapped Up | Strength | -3.72% | |
| 20 DMA Resistance | Bearish | 2.04% | |
| Down 3 Days in a Row | Weakness | 2.04% | |
| Fell Below 20 DMA | Bearish | 0.40% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 2 hours ago |
| Down 2 % | about 2 hours ago |
| Down 1% | about 2 hours ago |
| 20 DMA Resistance | about 2 hours ago |
| 10 DMA Resistance | about 2 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It holds rights to imetelstat, a telomerase inhibitor in Phase 2/3 clinical trials, which inhibits the uncontrolled proliferation of malignant progenitor cells in hematologic myeloid malignancies to reduce dysfunctional blood cell production and enable recovery of normal blood cell production. The company was founded in 1990 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cell Senescence Geron Corporation Haematopoiesis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cell Senescence Geron Corporation Haematopoiesis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.3 |
| 52 Week Low | 1.64 |
| Average Volume | 13,823,493 |
| 200-Day Moving Average | 2.44 |
| 50-Day Moving Average | 3.42 |
| 20-Day Moving Average | 3.82 |
| 10-Day Moving Average | 3.81 |
| Average True Range | 0.23 |
| RSI (14) | 54.13 |
| ADX | 36.98 |
| +DI | 20.35 |
| -DI | 13.96 |
| Chandelier Exit (Long, 3 ATRs) | 3.62 |
| Chandelier Exit (Short, 3 ATRs) | 4.04 |
| Upper Bollinger Bands | 4.13 |
| Lower Bollinger Band | 3.50 |
| Percent B (%b) | 0.49 |
| BandWidth | 16.59 |
| MACD Line | 0.11 |
| MACD Signal Line | 0.15 |
| MACD Histogram | -0.0373 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.17 | ||||
| Resistance 3 (R3) | 4.19 | 4.08 | 4.11 | ||
| Resistance 2 (R2) | 4.08 | 3.99 | 4.08 | 4.09 | |
| Resistance 1 (R1) | 3.95 | 3.94 | 3.90 | 3.93 | 4.07 |
| Pivot Point | 3.84 | 3.84 | 3.82 | 3.84 | 3.84 |
| Support 1 (S1) | 3.71 | 3.75 | 3.66 | 3.69 | 3.55 |
| Support 2 (S2) | 3.60 | 3.70 | 3.60 | 3.53 | |
| Support 3 (S3) | 3.47 | 3.60 | 3.51 | ||
| Support 4 (S4) | 3.45 |
